Investigations on neuropeptide Y and histamine receptors by fluorescence-based and radiochemical methods [PDF]
In the last three decades, a large amount of experimental data (for example Förster resonance energy transfer (FRET) at fluorescently labelled receptors) supported the hypothesis of the dimerization of G-protein-coupled receptors (GPCR), including ...
Lopuch, Miroslaw
core +1 more source
Neuropeptide Y modulates steroid production of human adrenal H295R cells through Y1 receptors [PDF]
Neuropeptide Y (NPY) is abundantly expressed in the nervous system and acts on target cells through NPY receptors. The human adrenal cortex and adrenal tumors express NPY receptor subtype Y1, but its function is unknown. We studied Y1-mediated signaling,
Reubi, J.C. +13 more
core +1 more source
New antagonist agents of neuropeptide y receptors
In the CNS, NPY has been implicated in obesity and feeding, endocrine function and metabolism. Potent and selective rNPY antagonists will be able to probe the merits of this approach for the treatment of obesity.
Ignacio Aldana +8 more
doaj +1 more source
Neuropeptide Y receptors; antisecretory control of intestinal epithelial function
Neuropeptide Y receptors; antisecretory control of intestinal epithelial ...
HM Cox (14474847)
core
Investigation of Neuropeptide Y as a metabolic marker and its effects on adipose vasculature and brainstem astrocytes [PDF]
Subsets of morbidly obese patients do not appear to exhibit the expected comorbidities, as well as the fact that heightened sympathetic nervous system (SNS) activity has been known to affect metabolism.
Casale, C
core
Neuropeptide Receptors: Novel Targets for HIV/AIDS Therapeutics
The vasoactive intestinal peptide/pituitary adenylyl cyclase-activating polypepetide (VPAC) receptors are important for many physiologic functions, including glucose homeostasis, neuroprotection, memory, gut function, modulation of the immune system and ...
Donald R. Branch
doaj +1 more source
Neuropeptide Y receptors: a promising target for cancer imaging and therapy.
Neuropeptide Y (NPY) was first identified from porcine brain in 1982, and plays its biological functions in humans through NPY receptors (Y1, Y2, Y4 and Y5).
Li, Juan, Wu, Aiguo, Tian, Yuchen
core
C.elegans neuropeptide connectome ligand-receptor interactions used EC50 500nM cutoff
Interactions between neuropeptide ligand and GPCR receptors to build the neuropeptide connectome of C.elegans. Threshold set at EC50 500nM.
Lidia Ripoll-Sánchez (17031075)
core +1 more source
Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy.
International audienceThe recent development of selective and highly potent nonpeptide antagonists for peptide receptors has constituted a major breakthrough in the field of neuropeptide research.
Betancur, Catalina +5 more
core +3 more sources
Cell-Free Expression and Photo-Crosslinking of the Human Neuropeptide Y2 Receptor
G protein-coupled receptors (GPCRs) represent a large family of different proteins, which are involved in physiological processes throughout the entire body. Furthermore, they represent important drug targets. For rational drug design, it is important to
Lisa Maria Kögler +3 more
doaj +1 more source

